Carnival Corporation & plc (CUK)

NYSE: CUK · Real-Time Price · USD

26.78

+0.01 (0.04%)

At close: Aug 6, 2025, 4:00 PM

26.78

0.00 (0.00%)

After-hours: Aug 6, 2025, 7:00 PM EDT

Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	May '25 May 31, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2016 - 2020
Operating Revenue	25,972	25,021	21,593	12,169	1,908	5,594	Upgrade
Revenue	25,972	25,021	21,593	12,169	1,908	5,594	Upgrade
Revenue Growth (YoY)	10.82%	15.88%	77.44%	537.79%	-65.89%	-73.14%	Upgrade
Cost of Revenue	11,765	11,627	10,775	8,359	2,717	4,760	Upgrade
Gross Profit	14,207	13,394	10,818	3,810	-809	834	Upgrade
Selling, General & Admin	3,536	3,476	3,078	2,523	1,896	1,885	Upgrade
Other Operating Expenses	3,855	3,842	3,514	2,965	1,346	1,625	Upgrade
Operating Expenses	10,047	9,875	8,962	7,763	5,475	5,751	Upgrade
Operating Income	4,160	3,519	1,856	-3,953	-6,284	-4,917	Upgrade
Interest Expense	-1,552	-1,755	-2,066	-1,609	-1,601	-895	Upgrade
Interest & Investment Income	53	93	233	74	12	18	Upgrade
Other Non Operating Income (Expenses)	109	96	-40	-127	-145	-44	Upgrade
EBT Excluding Unusual Items	2,770	1,953	-17	-5,615	-8,018	-5,838	Upgrade
Impairment of Goodwill	-	-	-	-	-226	-2,096	Upgrade
Gain (Loss) on Sale of Investments	-	-	-21	-30	-17	107	Upgrade
Gain (Loss) on Sale of Assets	41	41	88	7	-	-	Upgrade
Asset Writedown	-	-	-	-440	-591	-1,967	Upgrade
Other Unusual Items	-268	-79	-111	-1	-670	-459	Upgrade
Pretax Income	2,543	1,915	-61	-6,079	-9,522	-10,253	Upgrade
Income Tax Expense	18	-1	13	14	-21	-17	Upgrade
Net Income	2,525	1,916	-74	-6,093	-9,501	-10,236	Upgrade
Net Income to Common	2,525	1,916	-74	-6,093	-9,501	-10,236	Upgrade
Net Income Growth	179.62%	-	-	-	-	-	Upgrade
Shares Outstanding (Basic)	1,297	1,274	1,262	1,180	1,123	775	Upgrade
Shares Outstanding (Diluted)	1,424	1,398	1,262	1,180	1,123	775	Upgrade
Shares Change (YoY)	12.62%	10.78%	6.95%	5.08%	44.90%	11.99%	Upgrade
EPS (Basic)	1.95	1.50	-0.06	-5.16	-8.46	-13.21	Upgrade
EPS (Diluted)	1.84	1.44	-0.06	-5.16	-8.46	-13.21	Upgrade
EPS Growth	160.22%	-	-	-	-	-	Upgrade
Free Cash Flow	2,806	1,297	997	-6,610	-7,716	-9,921	Upgrade
Free Cash Flow Per Share	1.97	0.93	0.79	-5.60	-6.87	-12.80	Upgrade
Dividend Per Share	-	-	-	-	-	0.500	Upgrade
Dividend Growth	-	-	-	-	-	-75.00%	Upgrade
Gross Margin	54.70%	53.53%	50.10%	31.31%	-42.40%	14.91%	Upgrade
Operating Margin	16.02%	14.06%	8.60%	-32.48%	-329.35%	-87.90%	Upgrade
Profit Margin	9.72%	7.66%	-0.34%	-50.07%	-497.96%	-182.98%	Upgrade
Free Cash Flow Margin	10.80%	5.18%	4.62%	-54.32%	-404.40%	-177.35%	Upgrade
EBITDA	6,816	6,076	4,226	-1,678	-4,051	-2,676	Upgrade
EBITDA Margin	26.24%	24.28%	19.57%	-13.79%	-212.32%	-47.84%	Upgrade
D&A For EBITDA	2,656	2,557	2,370	2,275	2,233	2,241	Upgrade
EBIT	4,160	3,519	1,856	-3,953	-6,284	-4,917	Upgrade
EBIT Margin	16.02%	14.06%	8.60%	-32.48%	-	-87.90%	Upgrade
Effective Tax Rate	0.71%	-	-	-	-	-	Upgrade
Revenue as Reported	25,973	25,021	21,593	12,168	1,908	5,595	Upgrade

Updated Jun 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q